Apathy : Clinical Correlates in Parkinson’s disease Psychosis
Objective: To determine the frequency and clinical correlates of apathy in Parkinson’s disease (PD) psychosis. Background: The underlying pathology of apathy in PD psychosis, itself…Clinical Audit of Hospital Admissions for Parkinson Disease
Objective: To review Parkinson patients’ admissions and identify possible preventable admissions so as to develop measures to improve care for Parkinson patients Background: Many studies…Healthcare Resource Utilization and Costs of Parkinson’s Disease Dementia With Psychosis in the US Medicare Population
Objective: To describe healthcare resource use (HCRU) and related costs among Parkinson’s patients with dementia (PDD) and psychosis compared with other dementia types in a…Predictors of Retention for Carbidopa/Levodopa Intestinal Gel in Parkinson Disease
Objective: To identify predictors of discontinuation of levodopa/carbidopa intestinal gel therapy. Background: Although levodopa/carbidopa intestinal gel (LCIG) is an established treatment for Parkinson's disease complicated…Identifying delirium in people with Parkinson’s disease: the Determine-PD pilot study
Objective: To identify the prevalence of delirium in inpatients with Parkinson’s disease (PD). Background: People with PD may be at increased risk of delirium and…Comparison of Dementia Patients With and Without Parkinson’s Disease Before Dementia-related Psychosis Occurs: An Administrative Claims Data Analysis
Objective: Describe and compare patients with evidence of dementia-related psychosis diagnosed with Parkinson’s disease with dementia (PDD) versus patients with dementia but no Parkinson’s disease…Subacute Encephalopathy with Pimavanserin Treatment in Parkinson Disease
Objective: To report 3 cases of drug-induced encephalopathy in patients treated with pimavanserin (PVN) for Parkinson disease (PD) related psychosis (PDP). Background: Quetiapine and clozapine,…Electroconvulsive Therapy (ECT): An Effective Option for the Treatment of Medication-Resistant Psychiatric Symptoms in Huntington’s Disease: A Case Series and Review of the Literature
Objective: Through a single site case series, we investigate the use and effectiveness of electroconvulsive therapy (ECT) for the treatment of refractory psychiatric symptoms in…Visual subnetwork dysfunction in Parkinson’s patients with primary visual hallucinations
Objective: To evaluate impairments in the visual subnetwork in Parkinson’s disease (PD) patients with psychosis using BOLD fMRI Background: Psychosis occurs in 20-70% of patients…Use of Inappropriate Antipsychotics Among US Long-Term Care Residents with Parkinson’s Disease Psychosis
Objective: To characterize the use of inappropriate antipsychotic therapies among residents with Parkinson’s disease psychosis (PDP) in long-term care (LTC) settings in the US. Background:…
- « Previous Page
- 1
- …
- 7
- 8
- 9
- 10
- 11
- …
- 14
- Next Page »